Reaction Details |
| Report a problem with these data |
Target | C-C chemokine receptor type 5 |
---|
Ligand | BDBM50339034 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_729858 (CHEMBL1697612) |
---|
IC50 | >1000±n/a nM |
---|
Citation | Xue, CB; Chen, L; Cao, G; Zhang, K; Wang, A; Meloni, D; Glenn, J; Anand, R; Xia, M; Kong, L; Huang, T; Feng, H; Zheng, C; Li, M; Galya, L; Zhou, J; Shin, N; Baribaud, F; Solomon, K; Scherle, P; Zhao, B; Diamond, S; Emm, T; Keller, D; Contel, N; Yeleswaram, S; Vaddi, K; Hollis, G; Newton, R; Friedman, S; Metcalf, B. Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 Activity. ACS Med Chem Lett1:483-487 (2010) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
C-C chemokine receptor type 5 |
---|
Name: | C-C chemokine receptor type 5 |
Synonyms: | C-C CKR-5 | C-C chemokine receptor type 5 | CC-CKR-5 | CCR-5 | CCR5 | CCR5/mu opioid receptor complex | CCR5_HUMAN | CD_antigen=CD195 | CHEMR13 | CMKBR5 | HIV-1 fusion coreceptor |
Type: | Enzyme |
Mol. Mass.: | 40540.21 |
Organism: | Homo sapiens (Human) |
Description: | P51681 |
Residue: | 352 |
Sequence: | MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKR
LKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFII
LLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSS
HFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTI
MIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFV
GEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL
|
|
|
BDBM50339034 |
---|
n/a |
---|
Name | BDBM50339034 |
Synonyms: | (4,6-dimethylpyrimidin-5-yl)(4-((S)-4-((1S,2S)-2-hydroxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl)-4-methylpiperidin-1-yl)methanone | CHEMBL1688244 |
Type | Small organic molecule |
Emp. Form. | C28H36F3N5O2 |
Mol. Mass. | 531.6129 |
SMILES | C[C@H]1CN(CCN1[C@@H]1[C@@H](O)Cc2cc(ccc12)C(F)(F)F)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C |r| |
Structure |
|